Ketotifen Unit Dose Stulln (Ketotifen)

Ketotifen works by selectively blocking histamine H1 receptors on the conjunctival surface, preventing histamine‑induced itching and vasodilation. It also stabilises mast cells, limiting the release of inflammatory mediators like leukotrienes and prostaglandins, which together reduce ocular inflammation.

The dosing regimen for ketotifen eye drops is determined by the prescribing ophthalmologist based on the severity of the condition, patient age and response to therapy. The prescriber will specify the number of drops and frequency appropriate for each individual.

Safety data for ketotifen in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. Healthcare providers should weigh potential benefits against risks and consider alternative therapies when treating pregnant or nursing patients.

To place an order, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketotifen combines H1‑receptor antagonism with mast‑cell stabilisation, offering both immediate symptom relief and longer‑term control of allergic inflammation. Compared with agents that act solely as H1 antagonists, ketotifen may provide more sustained reduction of ocular itching and redness, especially in chronic conditions.

Ketotifen Unit Dose Stulln should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the unit‑dose containers from moisture, direct sunlight and extreme temperatures to maintain product stability.

The medication is supplied as a unit‑dose dropper. The patient should wash hands, tilt the head back, pull down the lower eyelid, and instil the prescribed number of drops into the conjunctival sac. Avoid touching the tip of the dropper to the eye or any surface.

Serious risks, though rare, include severe allergic reactions such as angio‑edema or anaphylaxis, corneal ulceration, persistent eye pain, sudden vision loss and significant intra‑ocular pressure elevation. Any of these symptoms require immediate medical attention.

Ketotifen eye drops should not be used by individuals with a known hypersensitivity to ketotifen or any excipients in the formulation. Patients with active ocular infections or severe corneal disease should avoid use until evaluated by an eye‑care professional.